Title : Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review.

Pub. Date : 2014 Dec

PMID : 25111859






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Weighted median of mOS was 9.7 months in cisplatin group and 9.5 months in oxaliplatin group. Cisplatin Moloney sarcoma oncogene Mus musculus
2 Sensitivity analysis including only the studies with the standard regimen of cisplatin (25-35 mg/m(2) administered on days 1 and 8) showed that the weighted median of mOS increased from 9.7 to 11.7 months but Gem/CDDP regimen remained more toxic than Gemox regimen. Cisplatin Moloney sarcoma oncogene Mus musculus